Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Sep. 30, 2021
Current Assets:
Cash and cash equivalents	$ 24,712	$ 31,153
Available-for-sale securities	2,007	7,717
Accounts receivable, net of allowances of $120 and $119 as of March 31, 2022 and September 30, 2021, respectively	11,037	9,169
Contract assets — royalties and license fees	7,242	7,091
Inventories, net	9,471	6,760
Income tax receivable	2,305	1,912
Prepaids and other	7,907	6,453
Total Current Assets	64,681	70,255
Property and equipment, net	29,079	30,090
Available-for-sale securities		2,002
Deferred income taxes	7,181	5,867
Intangible assets, net	33,511	37,054
Goodwill	44,248	45,606
Other assets	5,487	3,718
Total Assets	184,187	194,592
Current Liabilities:
Accounts payable	2,114	1,783
Accrued liabilities:
Compensation	5,689	8,480
Accrued other	6,547	4,905
Short-term borrowings	10,000	10,000
Deferred revenue	4,019	4,647
Total Current Liabilities	28,369	29,815
Deferred revenue, less current portion	8,423	10,301
Deferred income taxes	2,372	2,742
Other long-term liabilities	11,760	11,649
Total Liabilities	50,924	54,507
Commitments and Contingencies (Note 10)
Stockholders’ Equity:
Series A Preferred stock — $.05 par value, 450 shares authorized; no shares issued and outstanding
Common stock — $.05 par value, 45,000 shares authorized; 13,990 and 13,899 shares issued and outstanding as of March 31, 2022 and September 30, 2021, respectively	700	695
Additional paid-in capital	24,827	21,598
Accumulated other comprehensive (loss) income	(1,434)	1,727
Retained earnings	109,170	116,065
Total Stockholders’ Equity	133,263	140,085
Total Liabilities and Stockholders’ Equity	$ 184,187	$ 194,592